A detailed history of Bridgeway Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 618,075 shares of PFE stock, worth $17 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
618,075
Previous 680,662 9.2%
Holding current value
$17 Million
Previous $18.9 Million 8.44%
% of portfolio
0.42%
Previous 0.4%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $1.58 Million - $1.85 Million
-62,587 Reduced 9.2%
618,075 $17.3 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $5.55 Million - $6.37 Million
214,410 Added 45.99%
680,662 $18.9 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $2.51 Million - $3.26 Million
96,185 Added 25.99%
466,252 $13.4 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $906,735 - $1.06 Million
28,256 Added 8.27%
370,067 $12.3 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $9.79 Million - $11.3 Million
270,999 Added 382.7%
341,811 $12.5 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $334,815 - $435,880
8,500 Added 13.64%
70,812 $2.89 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $6.42 Million - $8.38 Million
-153,812 Reduced 71.17%
62,312 $3.19 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $4.83 Million - $5.89 Million
-110,300 Reduced 33.79%
216,124 $9.46 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $1.34 Million - $1.59 Million
-28,750 Reduced 8.09%
326,424 $17.1 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $8.04 Million - $9.96 Million
175,750 Added 97.95%
355,174 $18.4 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $2.61 Million - $3.86 Million
-63,100 Reduced 26.02%
179,424 $10.6 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $586,787 - $753,779
-14,950 Reduced 5.81%
242,524 $10.4 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $743,336 - $842,076
-20,700 Reduced 7.44%
257,474 $10.1 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $284,665 - $321,045
-8,500 Reduced 2.97%
278,174 $10.1 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $20.8 Million - $26.5 Million
-622,600 Reduced 68.47%
286,674 $10.6 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $19.2 Million - $22.5 Million
-603,300 Reduced 39.89%
909,274 $33.4 Million
Q2 2020

Aug 31, 2020

BUY
$30.12 - $36.54 $753,000 - $913,500
25,000 Added 1.68%
1,512,574 $49.5 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $9.75 Million - $11.8 Million
-323,600 Reduced 17.87%
1,487,574 $48.6 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $9.53 Million - $13.6 Million
-352,650 Reduced 16.3%
1,811,174 $59.1 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $6.82 Million - $7.74 Million
-207,200 Reduced 8.74%
2,163,824 $84.8 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $4.9 Million - $6.35 Million
150,750 Added 6.79%
2,371,024 $85.2 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $2.29 Million - $2.57 Million
-61,800 Reduced 2.71%
2,220,274 $96.2 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $3.89 Million - $4.27 Million
-103,600 Reduced 4.34%
2,282,074 $96.9 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $592,438 - $675,444
-15,400 Reduced 0.64%
2,385,674 $104 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $4.92 Million - $5.97 Million
142,700 Added 6.32%
2,401,074 $106 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $10.6 Million - $11.3 Million
320,900 Added 16.56%
2,258,374 $81.9 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $35,101 - $40,722
-1,100 Reduced 0.06%
1,937,474 $68.8 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $775,623 - $822,962
23,320 Added 1.22%
1,938,574 $70.2 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $59.4 Million - $65.4 Million
1,915,254
1,915,254 $68.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.